Adis, part of Springer Nature, is a prominent international publisher specializing in drug-focused content and solutions tailored for professionals in the pharmaceutical and biotech industries. The company provides a comprehensive range of medical publications, including journals and newsletters that focus on drugs and medical devices. Adis serves a global audience, including medical researchers, practitioners, and regulatory professionals, offering valuable resources for drug regulation and reimbursement. Additionally, their offerings extend to adjacent markets such as finance and consulting, making them a key player in the healthcare publishing sector.